Back to ProShare Advisors LLC ProShare Advisors LLC

NVCRNVCR
Showing 8 of 28 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in NOVOCURE LTD

ProShare Advisors LLC holds 17,803 shares of NVCR (NOVOCURE LTD), worth $269,715 as of 2026-Q2. The position was decreased (-10.2% shares). NVCR represents 0.0% of ProShare Advisors LLC's portfolio.

Current Value

$269,715

Current Shares

17,803

Total Value Change

-$144,778

Total Shares Change

-8,716

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
17,803
-10.2%
$269,7150.0%$15.15
0
2026-Q1
Decreased
19,820
-15.6%
$216,0390.0%$13.30
0
2025-Q4
Increased
23,493
+10.0%
$303,7650.0%$13.22
26
2025-Q3
Decreased
21,357
-14.6%
$275,9320.0%$12.92
0
2025-Q2
Decreased
24,998
-10.8%
$444,9640.0%$18.00
0
2025-Q1
Decreased
28,013
-20.2%
$499,1920.0%$18.86
0
2024-Q4
Increased
35,115
+32.4%
$1M0.0%$30.08
32
2024-Q3
New
26,519
-
$414,4930.0%$15.61
33

Other major holders of NVCR: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, BAILLIE GIFFORD & CO, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used